Subgroup analysis of double-blind, placebo-controlled Ph. 2 study of nanvuranlat in treatment of pre-treated, advanced, refractory biliary tract cancer (BTC): Patients with high LAT1 expression and ...

AMD SVP Jack Huynh will take the stage late Tuesday night US time to talk about the company's latest plans for the PC market.